FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracycline 10 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracycline 10 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength numerator value False un Inferred relationship Some 1
    Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Estradiol 1.04 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Tetracycline 10 mg/mL cutaneous lotion Has concentration strength denominator value False un Inferred relationship Some 1
    Tetracycline 10 mg/mL cutaneous lotion Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely proparacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyproheptadine hydrochloride 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Rimantadine hydrochloride 10 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Rimantadine hydrochloride 10 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
    Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Estradiol 1.56 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Betamethasone 120 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Betamethasone 120 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Diprophylline 10.7 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Diprophylline 10.7 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Progesterone 100 mg vaginal tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Progesterone 100 mg vaginal tablet Count of base of active ingredient False un Inferred relationship Some
    Terbutaline sulfate 200 microgram/mL solution for inhalation Count of base of active ingredient False un Inferred relationship Some
    Terbutaline sulfate 200 microgram/mL solution for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
    Theophylline 5.33 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Theophylline 5.33 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 2
    Olopatadine hydrochloride 665 microgram/actuation nasal spray Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Betamethasone 500 microgram orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Betamethasone 500 microgram orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Promazine 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Promazine 2.5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False un Inferred relationship Some 1

    Start Previous Page 188 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start